Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis
- PMID: 8540703
- PMCID: PMC162868
- DOI: 10.1128/AAC.39.9.1984
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis
Erratum in
- Antimicrob Agents Chemother 1995 Dec;39(12):2835
Abstract
The antibacterial efficacy of the combination of amoxicillin and cefotaxime was assessed against 50 clinical strains of Enterococcus faecalis. For 48 of 50 strains, the MIC of amoxicillin that inhibited 50% of isolates tested decreased from 0.5 microgram/ml (range, 0.25 to 1 microgram/ml) to 0.06 microgram/ml (range, 0.01 to 0.25 microgram/ml) in the presence of only 4 micrograms of cefotaxime per ml. Alternatively, the MIC of cefotaxime that inhibited 50% of isolates tested decreased from 256 micrograms/ml (range, 8 to 512 micrograms/ml) to 1 micrograms/ml (range, 0.5 to 16 micrograms/ml) in the presence of only 0.06 microgram of amoxicillin per ml. For JH2-2, a reference strain of E. faecalis, the MICs of amoxicillin, cefotaxime, and amoxicillin in the presence of cefotaxime (4 micrograms/ml) were 0.5, 512, and 0.06 microgram/ml, respectively. By using a penicillin-binding protein (PBP) competition assay, it was shown that with cefotaxime, 50% saturation of PBPs 2 and 3 was obtained at very low concentrations (< 1 microgram/ml), while 50% saturation of PBPs 1, 4, and 5 was obtained with > or = 128 micrograms/ml. With amoxicillin, 50% saturation of PBPs 4 and 5 was obtained at 0.12 and 0.5 microgram/ml, respectively. Therefore, the partial saturation of PBPs 4 and 5 by amoxicillin combined with the total saturation of PBPs 2 and 3 by cefotaxime could be responsible for the observed synergy between these two compounds.
Similar articles
-
Resistance to cefotaxime and peptidoglycan composition in Enterococcus faecalis are influenced by exogenous sodium chloride.Microbiology (Reading). 1998 Oct;144(Pt 10):2679-2685. doi: 10.1099/00221287-144-10-2679. Microbiology (Reading). 1998. PMID: 9802009
-
Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.J Antimicrob Chemother. 1996 Mar;37(3):605-9. doi: 10.1093/jac/37.3.605. J Antimicrob Chemother. 1996. PMID: 9182117
-
Characterization of clinical isolates of beta-lactamase-negative, highly ampicillin-resistant Enterococcus faecalis.Antimicrob Agents Chemother. 1996 Oct;40(10):2420-2. doi: 10.1128/AAC.40.10.2420. Antimicrob Agents Chemother. 1996. PMID: 8891156 Free PMC article.
-
The role of penicillin-binding proteins in penicillin resistance of Streptococcus pneumoniae.Dev Biol Stand. 1995;85:115-23. Dev Biol Stand. 1995. PMID: 8586161 Review. No abstract available.
-
In vitro activity of cefodizime.Infection. 1992;20 Suppl 1:S3-8. doi: 10.1007/BF01709942. Infection. 1992. PMID: 1526673 Review.
Cited by
-
Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?Antimicrob Agents Chemother. 2020 Dec 16;65(1):e02099-20. doi: 10.1128/AAC.02099-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33046488 Free PMC article.
-
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes.Clin Infect Dis. 2021 Oct 20;73(8):1532-1536. doi: 10.1093/cid/ciab535. Clin Infect Dis. 2021. PMID: 34113990 Free PMC article.
-
Pharmacokinetic/Pharmacodynamic Index Linked to In Vivo Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis.Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0096622. doi: 10.1128/aac.00966-22. Epub 2023 Jan 25. Antimicrob Agents Chemother. 2023. PMID: 36695584 Free PMC article.
-
Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.PLoS One. 2018 Feb 20;13(2):e0192387. doi: 10.1371/journal.pone.0192387. eCollection 2018. PLoS One. 2018. PMID: 29462176 Free PMC article.
-
Development of an amoxicillin-radix scutellaria extract formulation and evaluation of its pharmacokinetics in pigs.BMC Vet Res. 2023 Sep 19;19(1):164. doi: 10.1186/s12917-023-03713-1. BMC Vet Res. 2023. PMID: 37726783 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous